Timber Hill’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,100	Closed	-$497K	–	2357
2017 Q1	$497K	Sell	4,100 -900	-18%	-$116K	0.06%	1487
2016 Q4	$612K	Sell	5,000 -800	-14%	-$97.9K	0.06%	1545
2016 Q3	$711K	Sell	5,800 -55,100	-90%	-$7.09M	0.07%	1300
2016 Q2	$7.11M	Buy	60,900 +31,100	+104%	+$4.41M	0.59%	417
2016 Q1	$4.15M	Buy	29,800 +100	+0.3%	+$14.7K	0.32%	593
2015 Q4	$5.67M	Sell	29,700 -88,600	-75%	-$15.5M	0.59%	501
2015 Q3	$18.5M	Buy	118,300 +5,800	+5%	+$1.06M	1.95%	212
2015 Q2	$20.3M	Buy	112,500 +25,700	+30%	+$4.44M	1.55%	187
2015 Q1	$15M	Buy	86,800 +54,500	+169%	+$9.86M	1.46%	237
2014 Q4	$5.98M	Sell	32,300 -4,500	-12%	-$834K	0.37%	495
2014 Q3	$6.1M	Sell	36,800 -22,900	-38%	-$3.76M	0.58%	526
2014 Q2	$9.33M	Buy	59,700 +3,400	+6%	+$537K	0.94%	352
2014 Q1	$8.56M	Buy	56,300 +48,300	+604%	+$7.68M	1.06%	408
2013 Q4	$1.06M	Sell	8,000 -2,300	-22%	-$276K	0.09%	1799
2013 Q3	$1.2M	Sell	10,300 -92,300	-90%	-$10.1M	0.1%	1820
2013 Q2	$9.46M	Buy	+102,600	New	+$9.89M	0.98%	466